Description
The abstract mentions 3BP2 as a novel target of Syk but provides no mechanistic details about this interaction. Understanding this pathway could reveal new therapeutic targets for Syk-related neurological disorders.
Gap type: unexplained_observation Source paper: [Syk inhibitors]. (None, None, PMID:23961675)